199 related articles for article (PubMed ID: 6116152)
1. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
[TBL] [Abstract][Full Text] [Related]
2. Localization of the source of hyperinsulinism: percutaneous transhepatic portal and pancreatic vein catheterization with hormone assay.
Cho KJ; Vinik AI; Thompson NW; Shields JJ; Porter DJ; Brady TM; Cadavid G; Fajans SS
AJR Am J Roentgenol; 1982 Aug; 139(2):237-45. PubMed ID: 6283872
[TBL] [Abstract][Full Text] [Related]
3. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
Hayashi M; Floyd JC; Pek S; Fajans SS
J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
5. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.
Rastogi GK; Sialy R; Sinha MK; Dash R; Chopra JS; Kataria RN
Acta Diabetol Lat; 1975; 12(5-6):309-23. PubMed ID: 181932
[TBL] [Abstract][Full Text] [Related]
6. Insulinoma with hypoglycemia and normal immunoreactive insulin but with an insulin-like activity restricted to the portal vein.
Mirouze J; Marchal G; Orsetti A; Jaffiol C; Monnier L; Baldet P; Piperno M; Hedon B
Acta Diabetol Lat; 1978; 15(3-4):205-11. PubMed ID: 212916
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
Cieslak SR; Hazelwood RL
Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies.
Friesen SR; Kimmel JR; Tomita T
Am J Surg; 1980 Jan; 139(1):61-72. PubMed ID: 6243207
[TBL] [Abstract][Full Text] [Related]
9. Accurate localization of insulinoma using percutaneous transhepatic portal venous sampling--usefulness of simultaneous measurement of plasma insulin and glucagon levels.
Kinoshita Y; Nonaka H; Suzuki S; Kondo T; Chihara K; Chiba T; Fujita T; Kotoura Y; Yamamura T
Clin Endocrinol (Oxf); 1985 Nov; 23(5):587-93. PubMed ID: 3002671
[TBL] [Abstract][Full Text] [Related]
10. The role of the splenic pancreatic lobe in regulating metabolic normalcy following 99% pancreatectomy in chickens.
Cieslak SR; Hazelwood RL
Gen Comp Endocrinol; 1986 Mar; 61(3):476-89. PubMed ID: 2870006
[TBL] [Abstract][Full Text] [Related]
11. Localization of insulinomas and islet cell hyperplasias by pancreatic vein catheterization and insulin assay.
Ingemansson S; Kühl C; Larsson LI; Lunderquist A; Lundquist I
Surg Gynecol Obstet; 1978 May; 146(5):724-34. PubMed ID: 205962
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative biochemical localization of insulinomas by quick radioimmunoassay.
Teichmann RK; Spelsberg F; Heberer G
Am J Surg; 1982 Jan; 143(1):113-5. PubMed ID: 6274209
[TBL] [Abstract][Full Text] [Related]
13. Insulin-producing islet cell tumors.
Fajans SS; Vinik AI
Endocrinol Metab Clin North Am; 1989 Mar; 18(1):45-74. PubMed ID: 2537193
[TBL] [Abstract][Full Text] [Related]
14. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and localization of an insulinoma with inappropriate hypoglycemia in relation to the level of immunoreactive insulin using gel chromatographic separation.
Kakita K; Horino M
Exp Clin Endocrinol; 1985 Apr; 85(2):167-75. PubMed ID: 2990974
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on fasting plasma levels of pancreatic hormones in man.
Berger D; Crowther RC; Floyd JC; Pek S; Fajans SS
J Clin Endocrinol Metab; 1978 Dec; 47(6):1183-9. PubMed ID: 400740
[TBL] [Abstract][Full Text] [Related]
17. Corticotrophin releasing factor: effects on circulating gut and pancreatic peptides in man.
Lytras N; Grossman A; Rees LH; Schally AV; Bloom SR; Besser GM
Clin Endocrinol (Oxf); 1984 Jun; 20(6):725-9. PubMed ID: 6147213
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
Marre M; Miller J; Helman AM; Assan R
Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
[TBL] [Abstract][Full Text] [Related]
19. Localization of occult insulin secreting tumors of the pancreas.
Kallio H; Suoranta H
Ann Surg; 1979 Jan; 189(1):49-52. PubMed ID: 215092
[TBL] [Abstract][Full Text] [Related]
20. Preoperative localization of a vasoactive intestinal peptide-secreting tumor by transhepatic portal venous sampling.
Parkman HP; Malet PF; Ogorek CP; Burke DR; Deveney CW
Am J Gastroenterol; 1988 May; 83(5):559-63. PubMed ID: 2834945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
